Note: Ingredients listed on restricted chemical lists
EC/CAS
203-157-5/103-90-2
Name of the chemical
N-(4-hydroxyphenyl) acetamide
Concentration
N/A
EC/CAS
236-675-5/13463-67-7
Name of the chemical
Reaction mass of titanium dioxide and silver chloride
Concentration
N/A
EC/CAS
9003-39-8
Name of the chemical
polyvinylpyrrolidone
Concentration
25-<27
General Information
Revision date
2021-08-18
Product name
DRISTAN TRIPLE ACTION
Product Synonyms
DRISTAN TRIPLE ACTION NF TABLET * DRISTAN TRIPLE ACCION NF TABLETA * MFC08605 *
Emergency telephone
VERISK 3E GLOBAL INCIDENT RESPONSE
Icons in SDS
Company Information
company name
GlaxoSmithKline UK
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H302, H315, H319, H351, H412
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
2.1 Classification of the substance or mixture
The mixture has been assessed and/or tested for its physical, health and environmental hazards and the following classification applies.
EU Classification
Regulation (EC) No 1272/2008 as amended
Health hazards
Acute toxicity, oral Category 4 H302 - Harmful if swallowed. Skin corrosion/irritation Category 2 H315 - Causes skin irritation. Serious eye damage/eye irritation Category 2 H319 - Causes serious eye irritation. Carcinogenicity Category 2 H351 - Suspected of causing cancer.
Environmental hazards
Hazardous to the aquatic environment, Category 3 H412 - Harmful to aquatic life with long-term aquatic hazard long lasting effects. Hazard summary Harmful if swallowed. Causes skin and eye irritation. Suspected of causing cancer. See section 11 of the SDS for additional information on health hazards.
2.2 Label elements
Label according to Regulation (EC) No. 1272/2008 as amended
Contains
DEXTROMETHORPHAN HYDROBROMIDE, PARACETAMOL, PHENYLEPHRINE HYDROCHLORIDE
Signal word
Warning
Hazard statements
H302 Harmful if swallowed. H315 Causes skin irritation. H319 Causes serious eye irritation. H351 Suspected of causing cancer. H412 Harmful to aquatic life with long lasting effects.
Prevention
P201 Obtain special instructions before use. P202 Do not handle until all safety precautions have been read and understood. P264 Wash hands thoroughly after handling. P270 Do not eat, drink or smoke when using this product. P273 Avoid release to the environment. P280 Wear eye protection/face protection. P280 Wear protective gloves.
Response
P330 Rinse mouth. P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P308 + P313 IF exposed or concerned: Get medical advice/attention. P321 Specific treatment (see instructions on this label). P332 + P313 If skin irritation occurs: Get medical advice/attention. P337 + P313 If eye irritation persists: Get medical advice/attention.
Storage
P405 Store locked up.
Disposal
P501 Dispose of contents/container in accordance with local/regional/national/international regulations.
Supplemental label elements
98.9415 % of the mixture consists of component(s) of unknown acute dermal toxicity. 29.7415 % of the mixture consists of component(s) of unknown acute hazards to the aquatic environment. 26.3495 % of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment.
2.3 Other hazards
None known. See section 11 of the SDS for additional information on health hazards.
